Atypical Mature T-Cell Neoplasms: The Relevance of the Role of Flow Cytometry.

T-cell prolymphocytic leukemia angioimmunoblastic T-cell lymphoma diagnosis flow cytometry immunophenotype peripheral T-cell lymphoma not otherwise specified

Journal

OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322

Informations de publication

Date de publication:
2020
Historique:
received: 28 04 2020
accepted: 23 06 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 28 8 2020
Statut: epublish

Résumé

Lymphoproliferative disorders are a heterogeneous group of malignant clonal proliferations of lymphocytes whose diagnosis remains challenging, despite diagnostic criteria are now well established, due to their heterogeneity in clinical presentation and immunophenotypic profile. Lymphoid T-cell disorders are more rarely seen than B-cell entities and more difficult to diagnose for the absence of a specific immunophenotypic signature. Flow cytometry is a useful tool in diagnosing T-cell lymphoproliferative disorders since it is not only able to better characterize T-cell neoplasms but also to resolve some very complicated cases, in particular those in which a small size population of neoplastic cells is available for the analysis. Here, we report three patients with mature T-cell neoplasms with atypical clinical and biological features in which analysis of peripheral blood and bone marrow specimens by means of multicolor flow cytometry was very useful to identify and characterize three rare T-cell lymphoproliferative disorders, such as angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma not otherwise specified and T-cell prolymphocytic leukemia. The aim of this case series report is not only to describe three rare cases of lymphoproliferative neoplasms but also to raise awareness that a fast, highly sensitive, and reproducible procedure, such as flow cytometry immunophenotyping, can have a determinant diagnostic role in these patients.

Identifiants

pubmed: 32848413
doi: 10.2147/OTT.S258512
pii: 258512
pmc: PMC7425660
doi:

Types de publication

Case Reports

Langues

eng

Pagination

7605-7614

Informations de copyright

© 2020 Statuto et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

Hematol Oncol. 2018 Mar 30;:
pubmed: 29602219
Br J Haematol. 2001 Jan;112(1):201-3
pubmed: 11167803
Blood. 2015 Jul 23;126(4):454-62
pubmed: 26065657
Blood. 2003 Sep 15;102(6):2213-9
pubmed: 12750155
Ann Hematol. 1998 Sep;77(3):107-14
pubmed: 9797079
Haematologica. 2013 Aug;98(8):e81-2
pubmed: 23716537
Blood. 2008 May 1;111(9):4463-70
pubmed: 18292286
Br J Haematol. 2005 Aug;130(3):325-32
pubmed: 16042682
Ann Med. 2014 May;46(3):114-22
pubmed: 24512550
Clin Adv Hematol Oncol. 2008 Dec;6(12):899-909
pubmed: 19209140
Leuk Lymphoma. 2016 Dec;57(12):2804-2812
pubmed: 27105079
Bioinformatics. 2015 Dec 1;31(23):3844-6
pubmed: 26249808
Am J Clin Pathol. 2001 Oct;116(4):512-26
pubmed: 11601136
Blood. 2004 Aug 1;104(3):655-8
pubmed: 15073032
Ann Oncol. 2002 Jan;13(1):140-9
pubmed: 11863096
Leukemia. 1995 Oct;9(10):1783-6
pubmed: 7564526
Am J Clin Pathol. 2013 Nov;140(5):727-35
pubmed: 24124154
Crit Rev Oncol Hematol. 2011 Sep;79(3):321-9
pubmed: 20702104
N Engl J Med. 2012 May 17;366(20):1905-13
pubmed: 22591296
Am J Surg Pathol. 2004 Jan;28(1):54-61
pubmed: 14707864
Br J Haematol. 1994 Nov;88(3):629-32
pubmed: 7819080
Clin Chim Acta. 2015 Mar 10;442:46-8
pubmed: 25562817
Apoptosis. 2010 Jan;15(1):1-13
pubmed: 19856105
Oncotarget. 2017 Jun 27;8(37):61876-61889
pubmed: 28977911
Coll Antropol. 2010 Mar;34(1):241-5
pubmed: 20432757
Blood. 2017 Mar 2;129(9):1095-1102
pubmed: 28115369
Leukemia. 2005 Aug;19(8):1466-70
pubmed: 15959533
Cancer Treat Res. 2019;176:83-98
pubmed: 30596214
Br J Haematol. 2015 Mar;168(6):916-9
pubmed: 25316212
Diagn Cytopathol. 2012 Apr;40(4):346-51
pubmed: 21472868
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Am J Hematol. 2017 Jul;92(7):706-715
pubmed: 28516671
J Clin Oncol. 2006 Jun 1;24(16):2472-9
pubmed: 16636342
J Hematop. 2015 Dec;8(4):235-241
pubmed: 27559423
Am J Clin Pathol. 2007 Nov;128(5):854-64
pubmed: 17951210
J Clin Pathol. 2010 Feb;63(2):141-6
pubmed: 20154036
Crit Rev Oncol Hematol. 2008 Dec;68(3):264-71
pubmed: 18684638
Blood. 2018 Jul 5;132(1):111
pubmed: 29976781
Cancer. 1996 Jan 1;77(1):79-88
pubmed: 8630944
Pathology. 2018 Jan;50(1):74-87
pubmed: 29167021
Cytometry. 2002 Jun 15;50(3):177-90
pubmed: 12116341

Auteurs

Teodora Statuto (T)

Laboratory of Clinical Research and Advanced Diagnostics, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Fiorella D'Auria (F)

Unit of Clinical Pathology, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Luigi Del Vecchio (L)

CEINGE Biotecnologie Avanzate S.c.a.r.l, Federico II University, Naples, Italy.
Department of Molecular Medicine and Medical Biotechnology (DMMBM), Federico II University, Naples, Italy.

Giovanna Rosaria Mansueto (GR)

Hematology Department of Basilicata, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Oreste Villani (O)

Hematology Department of Basilicata, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Anna Vittoria Lalinga (AV)

Pathology Unit, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Luciana Possidente (L)

Pathology Unit, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Filomena Nozza (F)

Laboratory of Clinical Research and Advanced Diagnostics, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Gabriella Vona (G)

Laboratory of Clinical Research and Advanced Diagnostics, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Luciana Rago (L)

Radiotherapy Unit, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Giovanni Storto (G)

Department of Nuclear Medicine, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Vanessa Rebecca Gasparini (VR)

Department of Medicine, University of Padova - Veneto Institute of Molecular Medicine, VIMM, Padova, PD, Italy.

Renato Zambello (R)

Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, PD, Italy.

Giovanni D'Arena (G)

Hematology Department of Basilicata, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Luciana Valvano (L)

Laboratory of Clinical Research and Advanced Diagnostics, Centro Di Riferimento Oncologico Della Basilicata (IRCCS-CROB), Rionero in Vulture, Pz, Italy.

Classifications MeSH